Midcap Pharma Company Marksans Pharma Sees -9.82% Decline in Stock Price Today

Marksans Pharma, a midcap pharmaceutical company, saw a decline in its stock price today, opening with a loss of -9.82%. This underperformance was -1.85% lower than the sector's performance. The stock also touched an intraday low of Rs 270.9, further adding to the negative sentiment.

Despite this, Marksans Pharma's moving averages remain higher than the 20 day, 50 day, 100 day, and 200 day moving averages. However, it is currently lower than the 5 day moving average, indicating a recent downward trend.

In comparison to the Sensex, Marksans Pharma's 1 day performance was -2.03%, while the Sensex only saw a -1.04% decline. Over the past month, Marksans Pharma's performance has been positive at 21.11%, while the Sensex only saw a 1.01% increase.

It is important to note that this is not a recommendation to buy or sell Marksans Pharma's stock. This information is based on facts and figures and does not take into account any potential future developments or expert opinions. As a midcap company in the pharmaceutical industry, Marksans Pharma's stock performance will continue to be closely monitored by investors.